Literature DB >> 12838669

[Fasciola hepatica seroprevalence in the Elaziğ region].

Mustafa Kaplan1, Salih Kuk, Ahmet Kalkan, Kutbettin Demirdağ, Aykut Ozdarendeli.   

Abstract

In this study, for the detection of Fasciola hepatica infection seroprevalence in Elaziğ region (Eastern Anatolia), the presence of F. hepatica IgG antibodies were investigated by using a home-made enzyme immunoassay, in the sera of 540 healthy volunteers (254 males, 286 females) from different age groups (age range: 0-81 yrs, mean age: 33 +/- 20 yrs). The total seropositivity rate in this region of our country was found 2.78%, with no differences between males and females (respectively, 2.76% and 2.8%). F. hepatica IgG positive subjects were then evaluated for the parameters of age, educational and socioeconomical status, and it was found that there were no statistically significant differences.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12838669

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN： 0374-9096            Impact factor:   0.622


  9 in total

1.  Seroprevalence of fascioliasis in the eastern region of Turkey: an eight-year investigation.

Authors:  Yunus Emre Beyhan; Hasan Yılmaz
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

2.  Seroepidemiology of human fascioliasis in rural and nomad areas of Lorestan Province, western Iran, in 2016 and 2017.

Authors:  Babak Eshrati; Hamid Mokhayeri; Mohammad Bagher Rokni; Farnaz Kheirandish; Moharam Mafi; Ali Mokhayeri; Mohammad Hassan Kayedi
Journal:  J Parasit Dis       Date:  2020-08-01

3.  Genetic identification of Fasciola hepatica by ITS-2 sequence of nuclear ribosomal DNA in Turkey.

Authors:  Ahmet Erensoy; Salih Kuk; Mehmet Ozden
Journal:  Parasitol Res       Date:  2009-03-17       Impact factor: 2.289

4.  Fasciola hepatica infestation as a very rare cause of extrahepatic cholestasis.

Authors:  Ahmet Dobrucali; Rafet Yigitbasi; Yusuf Erzin; Oguzhan Sunamak; Erdal Polat; Hakan Yakar
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

5.  Ectopic fascioliasis mimicking a colon tumor.

Authors:  Ozer Makay; Baris Gurcu; Cemil Caliskan; Deniz Nart; Muge Tuncyurek; Mustafa Korkut
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

6.  The Endemicity of Human Fascioliasis in Guilan Province, Northern Iran: the Baseline for Implementation of Control Strategies.

Authors:  Keyhan Ashrafi; Farshid Saadat; Sandra O'Neill; Behnaz Rahmati; Hadid Amin Tahmasbi; John Pius Dalton; Abolhassan Nadim; Mohsen Asadinezhad; Sayed Mahmood Rezvani
Journal:  Iran J Public Health       Date:  2015-04       Impact factor: 1.429

7.  Toxocara seroprevalence in schizophrenic patients in Turkey.

Authors:  Mustafa Kaplan; Ahmet Kalkan; Salih Kuk; Kutbeddin Demirdag; Mehmet Ozden; S Sirri Kilic
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

8.  Seroprevalence of Human Fasciolosis in Lorestan Province, Western Iran, in 2015-16.

Authors:  Peyman Heydarian; Keyhan Ashrafi; Mehdi Mohebali; Eshrat Beigom Kia; Mojgan Aryaeipour; Ali Chegeni Sharafi; Hamid Mokhayeri; Arezoo Bozorgomid; Mohammad Bagher Rokni
Journal:  Iran J Parasitol       Date:  2017 Jul-Sep       Impact factor: 1.012

9.  Multiple liver masses in a patient with breast cancer, metastasis or not? An unexpected diagnosis: hepatic fascioliasis. A case report and overview of the literature from Turkey.

Authors:  Çağri Damar; Arif Emre Emek; Hüseyin Uçar; Harun Erdal; Işik Conkbayir; Çiğdem Öztunali
Journal:  BJR Case Rep       Date:  2016-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.